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INTRODUCTION
Tendon disorders are common and are treated on a daily
basis in orthopedic foot and ankle practices. Some tendons
are particularly vulnerable to primary degenerative
changes, such as the patellar, Achilles, rotator cuff, biceps,
posterior tibial, and fibular tendons.1
Significant advances in histopathology and research ima-
ging techniques have contributed to an improved under-
standing of the pathophysiology of tendon degeneration.2
However, both mechanical factors and vascular and neurolo-
gical disorders have limitations in explaining the etiology of
many cases.1,3,4 It is known that intense physical activity may
predispose an individual to tendinopathy, but some indivi-
duals have a predisposition with no clinically recognized
cause.
The literature suggests that individual characteristics,
including genetic inheritance, may influence the likelihood
of developing tendinopathy. Thus, there is a group of
individuals with a genetic background that causes increased
susceptibility to diseases of the tendon.
Matrix metalloproteinases (MMPs) are a pivotal family of
zinc-dependent enzymes responsible for the degradation of
extracellular matrix components, including basement mem-
brane collagen, interstitial collagen, fibronectin and various
proteoglycans, during normal remodeling, repair processes,
development and inflammation. MMPs are expressed in
response to specific stimuli by resident connective tissue
cells and by the major inflammatory cell types that invade
tissues during remodeling events, including tendinopathy.
MMP-8, or collagenase-2, was initially discovered in
neutrophils, in which it was thought to be exclusively
produced, but this enzyme was subsequently shown to be
expressed by a variety of other cell types, including
endothelial cells, smooth muscle cells, macrophages, poly-
morphonuclear leukocytes, gingival fibroblasts, keratino-
cytes, chondrocytes, odontoblasts5-10 and oral11 cancer cells.
It has been suggested that MMP-8 degrades type I collagen,
thereby contributing to tissue degradation and remodeling.12
MMP-8 is an important mediator of tissue destruction in
several inflammatory diseases and is related to cardiovas-
cular disease,9 bronchiectasis,13 pulmonary insufficiency,14
periodontitis,15-17 melanoma,18 cancer of the head and neck,19
and diabetic wound healing.20
The MMP-8 gene, located on chromosome 11, contains
functional polymorphisms in the promoter region, includ-
ing the substitution of a cytosine by a thymine at position -
799 (rs11225395).21 Alterations in this gene have been
associated with chronic dilatation of the bronchi13 and
breast cancer.22
The discovery of genetic markers of tendinopathy risk
could allow for the identification of susceptible indivi-
duals and, thus, early therapeutic interventions. MMPs
play key roles in tissue destruction and may have
important roles in the pathogenesis of tendinopathy.
Therefore, we hypothesized that the -799C/T polymorph-
ism in MMP-8 was associated with tendinopathy of the
primary posterior tibial tendon and could be a risk factor
for this condition.
MATERIALS AND METHODS
Subject selection
A total of 64 subjects were recruited from the patient pool
at the Foot and Ankle Group, Department of Orthopedics, at
the Traumatology Hospital of the University of Sa˜o Paulo,
Brazil. After a brief explanation of the study, as recom-
mended by the the hospital’s Research Ethics Committee,
subjects were identified according to age, sex, diagnosis,
pathology, medical history, postoperative complications,
medication use, personal history of systemic diseases, and
family history of infectious and inflammatory diseases. The
subjects were divided into two groups, with 66% female and
a mean age of 51 years:
Test group - 14 patients undergoing surgical procedures
who had pathological diagnoses of degenerative lesions of
the posterior tibial tendon.
Control group - 50 patients with posterior tibial tendon
integrity and with no signs of degeneration based on
magnetic resonance images produced to investigate com-
plaints about the ankle and foot.
All the subjects were in good general health and did not
display any of the following exclusion criteria: rheumatic
diseases, immunological diseases, diabetes, hepatitis or
prior or current infections in the topography of the foot
and ankle.
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DNA sampling and extraction
Buccal epithelial cells were sampled as described by
Trevilatto and Line (2000),23 and DNA extraction was
performed as by Aidar and Line (2007).24 The DNA
concentration was estimated by measuring the absorbance
ratio at 260/280 nm.
Polymerase chain reaction and restriction
endonuclease digestion
The MMP-8 genotypes were determined using the poly-
merase chain reaction - restricted fragment length poly-
morphism (PCR-RFLP) assay. The PCR primers used for
amplifying the MMP-8 polymorphism were the forward
primer 59-CAGAGACTCAAGTGGGA-39 and the reverse
primer 59-TTTCATTTGTGGAGGGGC-39. The PCR reactions
were performed in a total volume of 10 ml that contained
400 ng of genomic DNA, 5 ml of SYBR GREEN JUMPSTART
TAQ READY MIX (Amersham Pharmacia-Biotech, Uppsala,
Sweden) and 200 nmol of each primer. A 6-ml aliquot of each
PCR product was then digested with 1 unit of SfcI enzyme at
37 C˚ overnight.
Gel electrophoresis
The entire digest was electrophoresed on a 10% vertical
non-denaturing polyacrylamide gel at 20 mA. The gel was
stained with ethidium bromide.
Statistical analysis
The significance of the differences in the observed
frequencies of polymorphisms between both groups was
assessed using the chi-squared test, with a p,0.05 indicating
statistical significance.
RESULTS
The primers used for PCR efficiently amplified the MMP-
8 locus of interest, and the SfcI enzyme digestion cleaved the
PCR products into two fragments when the polymorphic
site contained the C allele (but not T). Electrophoresis
produced DNA bands of 32 and 74 bp for C alleles and a
band of 106 bp for T alleles, whereas the heterozygote
displayed a combination of both alleles (32, 74, and 106 bp).
There was a significant difference in the allele frequencies
of the control and test groups (p= 0.0006). In the control
group, the C allele was observed with a frequency of 71%,
whereas in the test group, the T allele was present at a
frequency of 64.3%. The C/C genotype was found in 66% of
the control group, whereas the T/T genotype was observed
in 50% of the test group (p= 0.0036). The frequencies of the
different alleles and genotypes of the MMP-8 gene are
shown in Table 1.
DISCUSSION
Posterior tibial tendon dysfunction has been associated
with obesity, hypertension, and diabetes.25 There has also
been an association with decreased vascular supply.26,27
However, some patients have a predisposition for this
condition without a clinically recognized cause, which
suggests that genetic inheritance may play an important
role in tendinopathy.
Some studies have already shown the influence of genetic
polymorphisms on tendinopathy. Mokone and collabora-
tors28 demonstrated that a polymorphism in the alpha 1
type V collagen gene (COL5A1) was associated with
Achilles tendon pathologies, with the A2 allele appearing
to play a protective role. The same group also demonstrated
the role of tenascin-C in Achilles tendon pathologies.29 By
analyzing a guanine-thymine (GT)n repeat polymorphism
in the tenascin-C gene, the authors showed that individuals
with 12 or 14 GT repeats had a 6-fold higher risk of
developing lesions in the Achilles tendon. A G/T poly-
morphism in the alpha-1 chain of type I collagen has been
associated with anterior cruciate ligament rupture30 but not
with Achilles tendon injuries.31 Raleigh and collaborators32
found that variants within the MMP-3 gene were associated
with Achilles tendinopathy but not Achilles tendon rupture.
The presence of cholesterol deposits in the tendons (tendon
xanthomas) of familial hypercholesterolemia patients has
been associated with polymorphisms in the reverse cho-
lesterol transport and low-density lipoprotein oxidation
pathways.33
In the present pilot study, the -799C/T polymorphism in
the promoter region of the MMP-8 gene was associated with
tendinopathy of the primary posterior tibial tendon. The C
allele was observed in the majority of the control group,
whereas the T allele was more frequent in the test group.
Patients bearing the T allele were more likely to have lesions
in the posterior tibial tendon. It is possible that this allele can
provide the molecular basis for a more intense degradation
of the extracellular matrix, which could lead to an increased
susceptibility to lesions in the posterior tibial tendon. The
clinical significance of these results, however, must be
interpreted with caution because the data were derived
from only 64 patients (including only 14 in the test group),
which provided a moderate power to detect a statistical
relationship between the polymorphism and the disease.
Indeed, genetic polymorphisms probably influence the
degeneration of tendons through the cumulative effect of
multiple polymorphisms that involve complex interactions
between multiple genes.34 Understanding the importance of
each polymorphic allele is necessary for assessing the
contribution of each polymorphism to the disease pheno-
type.35
Further investigations should determine the roles of
several genetic polymorphisms in maintaining homeostasis
of the tendon and in tendon pathologies. Because MMP-8
affects the degradation of a large number of extracellular
proteins and influences the degradation and remodeling of
injured tissues, the study of this gene is important for a
better understanding of the process of tendon degeneration.
The determination of the genetic patterns of patients with
tendinopathy could enable the identification of individuals
at higher risk of developing this disease and those with
Table 1 - The distribution of the MMP-8 alleles and
genotypes in the control and test groups.
MMP-8 Control Group Test Group p-value
n % n % (chi-squared)
Allele n = 100 n = 28
C 71 71.0 10 35.7 p= 0.0006
T 29 29.0 18 64.3
Genotype n = 50 n = 14 (Fisher’s exact test)
C/C 33 66.0 03 21.4
T/T 12 24.0 07 50.0 p = 0.0036
C/T 05 10.0 04 28.6
MMP-8 ploymorphisms and tendinopathy
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impaired regeneration capabilities. Thus, any identified
genetic markers may contribute to the appropriate pre-
operative selection, the preparation of strategies for preven-
tion, and individualized therapy to modulate the effects of
the genetic markers and increase the success rate of
treatments. Thus, it is important that a larger test group
be studied in the future to more conclusively identify the
influence of the -799C/T MMP-8 polymorphism on the
disease phenotype.
CONCLUSION
The utilized primers were effective for the PCR-RFLP
analysis of the -799C/T polymorphism in the MMP-8 gene.
The preliminary results indicate that this polymorphism
may be a risk factor for tendinopathy and could be used as a
genetic marker for the primary lesions of the posterior tibial
tendon.
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